Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chinese Medical Association | NETWORK |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Compare the efficacy and safety of closed-loop target controlled infusion of propofol or etomidate at general anesthesia in geriatric patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Propofol | Experimental | Target controlled infusion propofol, the effect compartment concentration is 3-4μg/ ml for induction and maintenance of anesthesia. |
|
| Etomidate | Experimental | Target controlled infusion etomidate, the effect compartment concentration is 0.5-1.0μg/ ml for induction and maintenance of anesthesia. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remifentanil | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Effect Compartment Concentration | The effect compartment concentration of etomidate or propofol are recorded at three time points,including time that patient's loss of eyelash reflex,after 30 minutes of loss of eyelash reflex and when the patient is awake (call then open their eyes). | From the beginning of induction to paitens'left of PACU, up to 4 hours |
| Measure | Description | Time Frame |
|---|---|---|
| vital signs | Systolic blood pressure, diastolic blood pressure, heart rate, respiration rate, pulse oxygen saturation recorded every 5 minutes during the operation. | From the beginning of induction to skin closure, up to 3 hours |
| The amount of drugs |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| He Jiaxuan | Department of Anesthesia, Second Affiliated Hospital of Xi'an Jiaotong University | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Cisatracurium | Drug |
|
|
| Sufentanil | Drug | Before skin closure, remifentanil is stopped and sufentanyl 0.1μg/kg is given by intravenous injection. |
|
| Bispectral index(BIS) monitor | Device | BiS is maintained at 40-60 during anesthesia. |
|
The amount of narcotics, sedation and muscle relaxation used in general anesthesia arr recorded when the operation is finished.
| From the beginning of induction to skin closure, up to 3 hours |
| Adrenal function |
| From entering the operating room to 48 h after induction of anesthesia. |
| ID | Term |
|---|---|
| D000077208 | Remifentanil |
| C101584 | cisatracurium |
| D017409 | Sufentanil |
| D008991 | Monitoring, Physiologic |
| ID | Term |
|---|---|
| D011422 | Propionates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D005283 | Fentanyl |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided